Section Arrow
Quote
CNSY.NASDAQ
- Cerenome, Inc.
Quotes are at least 15-min delayed:2026/09/19 12:40 EDT
Regular Hours
Last
 2.03
0 (0.00%)
Day High 
2.1 
Prev. Close
2.03 
1-M High
3.25 
Volume 
60.23K 
Bid
2
Ask
2.1
Day Low
2 
Open
2.01 
1-M Low
2 
Market Cap 
15.41M 
Currency 美元 
P/E 0.69 
%Yield -- 
10-SMA 2.4 
20-SMA 2.69 
50-SMA 3.34 
52-W High 23.425 
52-W Low 2 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
2.93/-2.58
Enterprise Value
15.42M
Balance Sheet
Book Value Per Share
0.72
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
RXRXRecursion Pharmaceuticals3.83+0.29+8.19%-- 
TCRTAlaunos Therapeutics Inc.1.2-0.4-25.00%-- 
ROIVRoivant Sciences Ltd39.77-0.21-0.53%-- 
SLXNSilexion Therapeutics Corp.0.4355+0.0555+14.61%-- 
IOVAIovance Biotherapeutics10.25+0.23+2.30%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.